Search

Your search keyword '"Stringa, Najada"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Stringa, Najada" Remove constraint Author: "Stringa, Najada"
42 results on '"Stringa, Najada"'

Search Results

2. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

3. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

4. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

8. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

9. Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women

10. Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use

15. Education and prosocial behaviours: a polygenic score approach

16. Pathway-specific polygenic risk score of AD-associated genetic variants associated with AD risk, resilience against AD, and progression to AD

17. The Effect of Alzheimer’s Disease-Associated Genetic Variants on Longevity

19. PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

20. Correction to:A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

21. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

22. Immune response and endocytosis pathways are associated with the escape of Alzheimers Disease

23. Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s disease

25. Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women

26. Physical Activity as Moderator of the Association Between APOE and Cognitive Decline in Older Adults: Results from Three Longitudinal Cohort Studies

27. Immune response and endocytosis pathways are associated with the resilience against Alzheimer’s Disease

28. Polygenic Risk Score of Longevity Predicts Longer Survival Across an Age Continuum.

29. The Longitudinal Aging Study Amsterdam: cohort update 2019 and additional data collections

30. Centenarian controls increase variant effect sizes by an average twofold in an extreme case–extreme control analysis of Alzheimer’s disease

31. P2‐134: THE ADDED VALUE OF EXTREME PHENOTYPES IN ALZHEIMER'S DISEASE CASE‐CONTROL STUDIES

32. Electrocardiographic abnormalities in Chagas disease in the general population: A systematic review and meta-analysis

33. Centenarian Controls Increase Variant Effect-sizes by an average two-fold in an Extreme Case-Extreme Control Analysis of Alzheimer’s Disease

34. A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer's Disease, Dementia with Lewy-Bodies and Frontotemporal Dementia, and Increases the Likelihood of Longevity

35. PLCG2 Protective Variant p.P522R Modulates Tau Pathology and Disease Progression in Patients with Mild Cognitive Impairment

36. A RARE GENETIC VARIANT IN THE PLCG2 GENE IS ASSOCIATED WITH A REDUCED RISK OF ALL MAJOR TYPES OF DEMENTIA AND AN INCREASED RISK TO REACH AN EXTREMELY OLD AGE

38. O5‐04‐01: A RARE GENETIC VARIANT IN THE PLCG2 GENE IS ASSOCIATED WITH A REDUCED RISK OF ALL MAJOR TYPES OF DEMENTIA AND AN INCREASED RISK TO REACH AN EXTREMELY OLD AGE.

39. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

40. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

41. Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women

42. PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment.

Catalog

Books, media, physical & digital resources